Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery
- Status
- COMPLETED
- Phase
- PHASE4
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine
- Status
- TERMINATED
- Phase
- PHASE4
Pembrolizumab + CVA21 in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)
- Status
- COMPLETED
- Phase
- PHASE1
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE2
Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
- Status
- COMPLETED
- Phase
- PHASE4